HK Stock MarketDetailed Quotes

03309 C-MER MEDICAL

Watchlist
  • 2.040
  • -0.020-0.97%
Not Open Sep 13 16:08 CST
2.56BMarket Cap40.80P/E (TTM)

C-MER MEDICAL Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(FY)Dec 31, 2023
(Q6)Jun 30, 2023
(FY)Dec 31, 2022
(Q6)Jun 30, 2022
(FY)Dec 31, 2021
(Q6)Jun 30, 2021
(FY)Dec 31, 2020
(Q6)Jun 30, 2020
(FY)Dec 31, 2019
Turnover
-2.92%922.5M
11.09%1.92B
7.79%950.26M
55.67%1.73B
69.06%881.56M
59.04%1.11B
99.20%521.44M
21.40%699.55M
-1.07%261.77M
34.20%576.21M
Operating income
-2.92%922.5M
11.09%1.92B
7.79%950.26M
55.67%1.73B
69.06%881.56M
59.04%1.11B
99.20%521.44M
21.40%699.55M
-1.07%261.77M
34.20%576.21M
Cost of sales
2.57%-633.38M
-1.62%-1.31B
-2.30%-650.11M
-70.24%-1.28B
-85.51%-635.52M
-49.24%-754.35M
-71.04%-342.59M
-31.33%-505.47M
-21.18%-200.3M
-37.44%-384.89M
Operating expenses
2.57%-633.38M
-1.62%-1.31B
-2.30%-650.11M
-70.24%-1.28B
-85.51%-635.52M
-49.24%-754.35M
-71.04%-342.59M
-31.33%-505.47M
-21.18%-200.3M
-37.44%-384.89M
Gross profit
-3.67%289.13M
38.25%618.96M
21.99%300.15M
24.98%447.7M
37.56%246.04M
84.58%358.23M
190.99%178.86M
1.44%194.08M
-38.10%61.47M
28.11%191.32M
Selling expenses
12.23%-60.64M
-16.59%-147.8M
-26.88%-69.09M
-0.26%-126.77M
-5.37%-54.45M
-80.93%-126.44M
-120.01%-51.68M
-50.94%-69.89M
-26.74%-23.49M
-74.71%-46.3M
Administrative expenses
10.84%-159.36M
-2.77%-354.93M
-12.24%-178.72M
-47.51%-345.35M
-52.27%-159.23M
-68.09%-234.12M
-97.88%-104.57M
-41.51%-139.28M
-27.13%-52.84M
-47.15%-98.42M
Special items of operating profit
137.63%4.29M
125.75%3.11M
111.92%1.81M
-144.54%-12.06M
-556.49%-15.16M
16.89%27.07M
320.81%3.32M
2,605.61%23.16M
-119.43%-1.5M
-84.08%856K
Operating profit
35.59%73.42M
427.11%119.34M
214.70%54.15M
-247.44%-36.48M
-33.65%17.21M
206.38%24.74M
258.40%25.93M
-82.98%8.08M
-134.88%-16.37M
-22.62%47.45M
Financing income
-15.82%7.46M
179.67%19.89M
555.70%8.87M
58.93%7.11M
-49.48%1.35M
-11.49%4.48M
9.85%2.68M
-62.50%5.06M
--2.44M
--13.48M
Financing cost
-32.20%-12.25M
7.80%-18.12M
4.33%-9.27M
-51.26%-19.66M
-57.56%-9.69M
-25.53%-13M
-28.89%-6.15M
-37.44%-10.35M
-38.95%-4.77M
-4,607.50%-7.53M
Share of profits of associates
-107.03%-241K
-91.63%3.16M
-78.91%3.43M
254.85%37.8M
6,676.11%16.24M
3,959.42%10.65M
-194.05%-247K
-40.82%-276K
---84K
---196K
Earning before tax
19.62%68.39M
1,206.88%124.27M
127.64%57.17M
-141.77%-11.23M
13.06%25.12M
973.28%26.88M
218.22%22.21M
-95.29%2.5M
-143.19%-18.79M
-13.01%53.21M
Tax
-3.03%-19.76M
-8.39%-37.93M
11.10%-19.18M
-228.77%-35M
-123.52%-21.57M
2.48%-10.65M
-184.83%-9.65M
22.50%-10.92M
67.37%-3.39M
24.25%-14.09M
After-tax profit from continuing operations
28.00%48.64M
286.77%86.34M
971.85%38M
-384.81%-46.23M
-71.78%3.55M
292.94%16.23M
156.65%12.56M
-121.50%-8.41M
-166.95%-22.18M
-8.10%39.12M
Earning after tax
28.00%48.64M
286.77%86.34M
971.85%38M
-384.81%-46.23M
-71.78%3.55M
292.94%16.23M
156.65%12.56M
-121.50%-8.41M
-166.95%-22.18M
-8.10%39.12M
Minority profit
116.93%17.87M
199.95%24.34M
173.11%8.24M
-332.43%-24.35M
-880.85%-11.27M
-159.97%-5.63M
3.93%-1.15M
6.36%-2.17M
-89.54%-1.2M
---2.31M
Profit attributable to shareholders
3.38%30.76M
383.42%62M
100.86%29.76M
-200.06%-21.88M
8.04%14.82M
450.00%21.86M
165.35%13.71M
-115.07%-6.25M
-162.15%-20.98M
-2.67%41.44M
Basic earnings per share
5.08%0.0248
379.10%0.0494
95.04%0.0236
-193.16%-0.0177
1.68%0.0121
433.33%0.019
160.41%0.0119
-114.39%-0.0057
-160.80%-0.0197
-4.81%0.0396
Diluted earnings per share
5.08%0.0248
379.10%0.0494
95.04%0.0236
-193.16%-0.0177
1.68%0.0121
433.33%0.019
160.41%0.0119
-114.73%-0.0057
-161.76%-0.0197
-4.21%0.0387
Currency Unit
HKD
HKD
HKD
HKD
HKD
HKD
HKD
HKD
HKD
HKD
Accounting Standards
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
Audit Opinions
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
Auditor
--
PricewaterhouseCoopers
--
PricewaterhouseCoopers
--
PricewaterhouseCoopers
--
PricewaterhouseCoopers
--
PricewaterhouseCoopers
(Q6)Jun 30, 2024(FY)Dec 31, 2023(Q6)Jun 30, 2023(FY)Dec 31, 2022(Q6)Jun 30, 2022(FY)Dec 31, 2021(Q6)Jun 30, 2021(FY)Dec 31, 2020(Q6)Jun 30, 2020(FY)Dec 31, 2019
Turnover -2.92%922.5M11.09%1.92B7.79%950.26M55.67%1.73B69.06%881.56M59.04%1.11B99.20%521.44M21.40%699.55M-1.07%261.77M34.20%576.21M
Operating income -2.92%922.5M11.09%1.92B7.79%950.26M55.67%1.73B69.06%881.56M59.04%1.11B99.20%521.44M21.40%699.55M-1.07%261.77M34.20%576.21M
Cost of sales 2.57%-633.38M-1.62%-1.31B-2.30%-650.11M-70.24%-1.28B-85.51%-635.52M-49.24%-754.35M-71.04%-342.59M-31.33%-505.47M-21.18%-200.3M-37.44%-384.89M
Operating expenses 2.57%-633.38M-1.62%-1.31B-2.30%-650.11M-70.24%-1.28B-85.51%-635.52M-49.24%-754.35M-71.04%-342.59M-31.33%-505.47M-21.18%-200.3M-37.44%-384.89M
Gross profit -3.67%289.13M38.25%618.96M21.99%300.15M24.98%447.7M37.56%246.04M84.58%358.23M190.99%178.86M1.44%194.08M-38.10%61.47M28.11%191.32M
Selling expenses 12.23%-60.64M-16.59%-147.8M-26.88%-69.09M-0.26%-126.77M-5.37%-54.45M-80.93%-126.44M-120.01%-51.68M-50.94%-69.89M-26.74%-23.49M-74.71%-46.3M
Administrative expenses 10.84%-159.36M-2.77%-354.93M-12.24%-178.72M-47.51%-345.35M-52.27%-159.23M-68.09%-234.12M-97.88%-104.57M-41.51%-139.28M-27.13%-52.84M-47.15%-98.42M
Special items of operating profit 137.63%4.29M125.75%3.11M111.92%1.81M-144.54%-12.06M-556.49%-15.16M16.89%27.07M320.81%3.32M2,605.61%23.16M-119.43%-1.5M-84.08%856K
Operating profit 35.59%73.42M427.11%119.34M214.70%54.15M-247.44%-36.48M-33.65%17.21M206.38%24.74M258.40%25.93M-82.98%8.08M-134.88%-16.37M-22.62%47.45M
Financing income -15.82%7.46M179.67%19.89M555.70%8.87M58.93%7.11M-49.48%1.35M-11.49%4.48M9.85%2.68M-62.50%5.06M--2.44M--13.48M
Financing cost -32.20%-12.25M7.80%-18.12M4.33%-9.27M-51.26%-19.66M-57.56%-9.69M-25.53%-13M-28.89%-6.15M-37.44%-10.35M-38.95%-4.77M-4,607.50%-7.53M
Share of profits of associates -107.03%-241K-91.63%3.16M-78.91%3.43M254.85%37.8M6,676.11%16.24M3,959.42%10.65M-194.05%-247K-40.82%-276K---84K---196K
Earning before tax 19.62%68.39M1,206.88%124.27M127.64%57.17M-141.77%-11.23M13.06%25.12M973.28%26.88M218.22%22.21M-95.29%2.5M-143.19%-18.79M-13.01%53.21M
Tax -3.03%-19.76M-8.39%-37.93M11.10%-19.18M-228.77%-35M-123.52%-21.57M2.48%-10.65M-184.83%-9.65M22.50%-10.92M67.37%-3.39M24.25%-14.09M
After-tax profit from continuing operations 28.00%48.64M286.77%86.34M971.85%38M-384.81%-46.23M-71.78%3.55M292.94%16.23M156.65%12.56M-121.50%-8.41M-166.95%-22.18M-8.10%39.12M
Earning after tax 28.00%48.64M286.77%86.34M971.85%38M-384.81%-46.23M-71.78%3.55M292.94%16.23M156.65%12.56M-121.50%-8.41M-166.95%-22.18M-8.10%39.12M
Minority profit 116.93%17.87M199.95%24.34M173.11%8.24M-332.43%-24.35M-880.85%-11.27M-159.97%-5.63M3.93%-1.15M6.36%-2.17M-89.54%-1.2M---2.31M
Profit attributable to shareholders 3.38%30.76M383.42%62M100.86%29.76M-200.06%-21.88M8.04%14.82M450.00%21.86M165.35%13.71M-115.07%-6.25M-162.15%-20.98M-2.67%41.44M
Basic earnings per share 5.08%0.0248379.10%0.049495.04%0.0236-193.16%-0.01771.68%0.0121433.33%0.019160.41%0.0119-114.39%-0.0057-160.80%-0.0197-4.81%0.0396
Diluted earnings per share 5.08%0.0248379.10%0.049495.04%0.0236-193.16%-0.01771.68%0.0121433.33%0.019160.41%0.0119-114.73%-0.0057-161.76%-0.0197-4.21%0.0387
Currency Unit HKDHKDHKDHKDHKDHKDHKDHKDHKDHKD
Accounting Standards HKASHKASHKASHKASHKASHKASHKASHKASHKASHKAS
Audit Opinions --Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion
Auditor --PricewaterhouseCoopers--PricewaterhouseCoopers--PricewaterhouseCoopers--PricewaterhouseCoopers--PricewaterhouseCoopers

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
% Chg

No Data